UK’s NICE seeks additional data on blood cancer drug Blincyto

Image: NICE has requested to provide additional data on Amgen’s Blincyto to treat acute lymphoblastic leukaemia. Photo: courtesy of cooldesign / FreeDigitalPhotos.net.